This comprehensive case study demonstrates Kymanox’s role in enabling commercial readiness for a breakthrough wearable injector device. Through strategic integration of stakeholder requirements, robust Intellectual Property (IP) development, scalable manufacturing expertise, and GMP solutions, the project advanced patient-centric technology and delivered scalable, efficient commercialization pathways for pharmaceutical partners, positioning for market leadership and a strong platform for future development.
CHALLENGE
SOLUTION
RESULTS
- Identify device requirements for a prefilled, preassembled, large-volume wearable injector for commercial readiness.
- Solidify the IP portfolio for the device to maximize brand value and patient experience.
- Develop a comprehensive plan for device design and manufacturing, ensuring scalability and reliability.
- Consolidated and synthesized requirements from patients, healthcare providers, component manufacturers, automation vendors, contract fill and finish companies and contract manufacturers to ensure both clinical fit and manufacturability.
- Established industry-leading IP focused on patient-centric design and enhanced commercial value for pharmaceutical partners.
- Developed robust in-house expertise covering both device design and manufacturing to maintain development cost and timeline control while delivering iterative improvements.
- Engineered advanced technologies for reliable needle insertion and container access, enabling a fully integrated, prefilled and preassembled wearable injector system.
- Ensured compatibility with GMP-ready filling operations for efficient scale-up.
- Completed a successful clinical trial with one of the industry’s first prefilled, preassembled large-volume wearable injectors.
- Produced a GMP-ready, fillable primary container configuration compatible with existing syringe filling lines.
- Achieved accelerated operational readiness and regulatory compliance for commercial launch.
- Positioned the client for leadership in wearable drug delivery with a platform support future innovation.